Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 37, 2002 - Issue 8
Submit an article Journal homepage
19
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Eradication of Helicobacter pylori Does Not Increase Acid Reflux in Patients with Mild to Moderate Reflux Oesophagitis

S. Tefera
,
J. G. Hatlebakk
,
A. Elnæs Berstad
&
A. Berstad
Pages 877-883 | Published online: 08 Jul 2009

  • O'Connor HJ, Cunnane K. Helicobacter pylori and gastrooesophageal reflux disease: a prospective study. Ir J Med Sci 1994:163:369-73.
  • Werdmuller BF, Loffeld RJ. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig Dis Sci 1997:42:103-5.
  • Boixeda D, Gisbert JP, Canton R, et al. Is there any association between Helicobacter pylori infection and gastroesophageal reflux disease? Med Clin (Bare) 1995:105:774-7.
  • Cheng EH, Bermanski P, Silversmith M, et al. Prevalence of Campylobacter pylori in esophagitis, gastritis, and duodenal ulcer. Arch Intern Med 1989:149:1373-5.
  • Csendes A, Smok G, Cerda G, et al. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barren's esophagus. Dis Esophagus 1997:10:38-42.
  • Goldblum JR, Vicari JJ, FaIk GW, et al. Inflammation and intestinal metaplasia of the gastric cardia the role of gastroesophageal reflux and H. pylori infection. Gastroenterology 1998:114:633-9.
  • Hackeisberge r A, Schultze V, Gunther T, et al. The prevalence of Helicobacter pylori gastritis in patients with reflux oesophagitis : a case-control study. Eur J Gastroenterol Hepatol 1998;10: 465-8.
  • Liston R, Pitt MA, Banarjee AK. Reflux oesophagitis and Helicobacter pylori infection in elderly patients. Postgrad Med J 1996:72:221-3.
  • De McCallum RW, Luca V, Marshall BJ, et al. Prevalence of Campylobacter-Vke, organisms in patients with gastro-esophageal reflux disease versus normals. Gastroenterology 1987;92:1524.
  • Vicari JJ, Peek RM, FaIk GW, et al. The seroprevalenc e of cagApositive Helicobacter pylori strains in the spectrum of gastroesophagea 1 reflux disease. Gastroenterology 1998; 115:50-7.
  • Sacca N, De Medici A, Rodino S, et al. Reflux oesophagitis : a complication of if. pylori eradication therapy? Endoscopy 1997; 29:224.
  • Labenz J, Blum AL, Bayerdorffer E, et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112:1442-7.
  • Hamada H, Haruma K, Mihara M, et al. High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther 2000:14:729-35.
  • Sonnenberg A, El-Serag HB. Clinical epidemiology and natural history of gastroesophagea 1 reflux disease. Yale J Biol Med 1999:72:81-92.
  • Berstad AE, Hatlebakk JG, Maartmann-Moe H, et al. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lanzoprazole. Gut 1997:41:740-7.
  • Kuipers EI, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996:334:1018-22.
  • Klinkenberg-Knol EC, Nefls F, Dent J, et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology 2000; 118:661-9.
  • Labenz J, Tillenburg B, Peitz U, et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996:110:725-32.
  • Tefera S, Hatlebakk JG, Berstad A. The effect of Helicobacter pylori eradication on gastro-oesophageal reflux. Aliment Pharmacol Ther 1999:13:915-20.
  • Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol 1996:20:1161-81.
  • Hatlebakk JG, Berstad A, Carting L, et al. Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Scand J Gastroenterol 1993:28:224-8.
  • Loof L, Gotell P, Elfberg B. The incidence of reflux oesophagitis. A study of endoscopy reports from a defined catchment area in Sweden. Scand J Gastroenterol 1993;28:113-8.
  • Hatlebakk JG, Berstad A. Endoscopie grading of reflux oesophagitis: what observations correlate with gastro-oesophageal reflux? Scand J Gastroenterol 1997:32:760-5.
  • Wilhelmsen I, Hatlebakk JG, Olafsson S, Berstad A. On demand therapy of reflux oesophagitis : a prospective study of symptoms, patient satisfaction and quality of life. Aliment Pharmacol Ther 1999:13:1035-40.
  • Hatlebakk JG, Hyggen A, Madsen PH, et al. Heartburn treatment in primary care: randomised, double blind study for 8 weeks. Br Med J 1999:319:550-3.
  • Berstad A, Olafsson S, Tefera S, et al. Bismuth therapy for Helicobacter pylori infection. A review of five years experience at a university hospital in Norway. J Physiol Pharmacol 1996;47: 31-49.
  • Berstad K, Wilhelmsen I, Berstad A. Biometrie evaluation of gastric urease activity in man. Scand J Gastroenterol 1992;27: 977-83.
  • Johnsson F, Joelsson B, Isberg PE Ambulatory 24 hour intraesophageal pH-monitoring in the diagnosis of gastroesophageal reflux disease. Gut 1987:28:1145-50.
  • Tefera S, Berstad A, Bang CJ, et al. Bismuth-based combination therapy for Helicobacter pylori-assoasted peptic ulcer disease (Metronidazole for eradication, ranitidine for pain). Am J Gastroenterol 1996:91:935-41.
  • Houben MH, Hensen EF, Rauws EA, et al. Randomized trial of omeprazole and clarithramycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistan t or -susceptible Helicobacter pylori strains. Aliment Pharmacol Ther 1999:13:883-9.
  • Lundell L, Ruth M, Sandberg N, et al. Does massive obesity promote abnormal gastroesophageal reflux? Dig Dis Sei 1995; 40:1632-5.
  • Boyd EJS. The prevalence of esophagitis in patients with duodenal ulcer or ulcer-like dyspepsia. Am J Gastroenterol 1996; 91:1539-43.
  • Sipponen P, Hyvarinen H, Siurala M. H. pylori corpus gastritis: relation to acid output. J Physiol Pharmacol 1996;47:151-9.
  • Yasunga Y, Shinomura Y, Kanayama S, et al. Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis. Gut 1996:35:1571-4.
  • Gutierrez O, MeIo M, Segura AM, et al. Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol 1997;32:664-8.
  • Shirota T, Kusano M, Kawamura O, et al. Helicobacter pylori infection correlates with severity of reflux esophagitis: with manometry findings. I Gastroenterol 1999;34:553-9.
  • Harry Hua-Xiang Xia et al. Helicobacter pylori infection, reflux esophagitis, and atrophie gastritis: an unexplored triangle. Am I Gastroenterol 1998;93:394-400.
  • Genta RM, Lew GM, Graham DY. Changes in the gastric mucosa following eradication of Helicobacter pylori. Mod Pathol 1993:6:281-9.
  • Solcia E, Villani L, Fiocca R, et al. Effects of eradication of Helicobacter pylori on gastritis on duodenal ulcerapatients. Scand J Gastroenterol 1994;33 Suppl 201:28-34.
  • Witteman EM, Mravunac M, Becx MI, et al. Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori. I Clin Pathol 1995:48:250-6.
  • Tucci A, PoIi L, Tosetti C, et al. Reversal of fundic atrophy after eradication of Helicobacter pylori. Am I Gastroenterol 1998;93: 1425-31.
  • Genta RM. Atrophy and atrophie gastritis: one step beyond the Sydney system. Ital I Gastroenterol Hepatol 1998;30 Suppl 3: S273-5.
  • Manes G, Mosca S, Laccetti M, et al. Helicobacter pylori infection, pattern of gastritis, and symptoms in erosive and nonerosive gastroesophageal reflux disease. Scand I Gastroenterol 1999:34:658-62.
  • El-Serag HB, Sonnenberg A, Jamal MM, et al. Corpus gastritis is protective against reflux oesophagitis. Gut 1999;45:181 -5.
  • Moayyedi P, Bardhan C, Young L, et al. Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology 2001;121:1120-6.
  • Lundell L, Miettinen P, Myrvold HE, et al. Lack of effect of acid suppression therapy on gastric atrophy. Nordic GERD Study Group. Gastroenterology 1999;117:319-26.
  • Mattioli S, Pilotti V, Spangaro M, et al. Reliability of 24-hour home esophageal pH monitoring in diagnosis of gastroesophageal reflux. Dig Dis Sci 1989;34:71 -8.
  • Weusten BL, Smout AJ. Analysis of 24-h oesophageal pH and pressure recordings. Eur J Gastroenterol Hepatol 1995;7:114751.
  • Wiener GI, Morgan TM, Copper IB, et al. Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci 1988;33:1127-33.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.